HomeCompareMCVEF vs KMB

MCVEF vs KMB: Dividend Comparison 2026

MCVEF yields 0.62% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $25.4K in total portfolio value
10 years
MCVEF
MCVEF
● Live price
0.62%
Share price
$27.25
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$64.97
Full MCVEF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — MCVEF vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCVEFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCVEF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCVEF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEF
Annual income on $10K today (after 15% tax)
$53.03/yr
After 10yr DRIP, annual income (after tax)
$55.22/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, KMB beats the other by $4,383.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEF + KMB for your $10,000?

MCVEF: 50%KMB: 50%
100% KMB50/50100% MCVEF
Portfolio after 10yr
$33.2K
Annual income
$2,643.65/yr
Blended yield
7.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

MCVEF
No analyst data
Altman Z
2.3
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEF buys
0
KMB buys
0
No recent congressional trades found for MCVEF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCVEFKMB
Forward yield0.62%5.25%
Annual dividend / share$0.17$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$20.6K$45.9K
Annual income after 10y$64.97$5,222.34
Total dividends collected$638.00$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MCVEF vs KMB ($10,000, DRIP)

YearMCVEF PortfolioMCVEF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,762$62.39$11,314$614.45$552.00KMB
2$11,579$62.75$12,867$760.19$1.3KKMB
3$12,452$63.09$14,713$945.27$2.3KKMB
4$13,387$63.41$16,924$1,181.90$3.5KKMB
5$14,388$63.71$19,596$1,486.64$5.2KKMB
6$15,459$64.00$22,850$1,882.16$7.4KKMB
7$16,606$64.26$26,849$2,399.80$10.2KKMB
8$17,832$64.51$31,812$3,083.36$14.0KKMB
9$19,145$64.75$38,033$3,994.72$18.9KKMB
10$20,551$64.97$45,918$5,222.34$25.4KKMB

MCVEF vs KMB: Complete Analysis 2026

MCVEFStock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this MCVEF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEF vs SCHDMCVEF vs JEPIMCVEF vs OMCVEF vs KOMCVEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.